Home / Sector / Healthcare Shares / Regis Healthcare names Andrew Kinkade as new CEO

Regis Healthcare names Andrew Kinkade as new CEO

Regis Healthcare appoints Andrew Kinkade as CEO, unveiling new leadership strategy and key remuneration details.

Posted by
Laura Stewart
Author bio Laura Stewart is a Finance Editor at The Motley Fool, where she covers Australian and international equity markets. She joined the company in 2022, following a career transition from legal advisory work in Southeast Asia into the investment industry. Prior to her current editorial role, Laura spent three years as an Equity Analyst and Writer, producing investment research across the ASX, NYSE, and NASDAQ. Her coverage included small-cap growth companies, thematic investment ideas, and high-quality U.S.-listed businesses. Laura holds a Master of Applied Finance and brings additional expertise in accounting, taxation, and estate and wealth planning from her postgraduate studies. She also has a background in law and communications, which supports her analytical and reporting work in financial markets. Outside of work, she enjoys spending time in the Adelaide Hills with her flock of sheep. Education Laura holds a Bachelor of Laws, a Bachelor of Communication (Journalism), and a Bachelor of Commerce with majors in Accounting and Corporate Finance. In 2025, she completed a Master of Applied Finance at the University of Adelaide, receiving postgraduate awards in Accounting Concepts & Methods, Ethical Principles in Accounting & Finance, Real Estate Valuation & Investment, and Tax, Estate & Wealth Planning. Social media LinkedIn FYI – I am taking a break from social media at the moment, so this account isn’t active at the moment, but I will let you know when I rejoin. Favorite investment quote "Compound interest is the eighth wonder of the world. He who understands it, earns it... he who doesn't... pays it." — Albert Einstein
Published
| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Regis Healthcare Ltd (ASX: REG) share price is in focus today after the company announced the appointment of Andrew Kinkade as its new Managing Director and Chief Executive Officer. Kinkade joins Regis with an extensive leadership background in aged care, healthcare and finance.

CEO of a company talking.

Image source: Getty Images

What did Regis Healthcare report?

  • Appointment of Andrew Kinkade as new Managing Director & CEO, commencing 20 July 2026
  • Total fixed remuneration of $900,000 per annum, inclusive of superannuation
  • Short Term Incentive of up to 50% of TFR and Long Term Incentive of up to 100% of TFR, subject to performance
  • Sign-on equity award of $1.6 million in Performance Rights, subject to shareholder approval

What else do investors need to know?

Andrew Kinkade brings more than 20 years of experience across aged care, healthcare, private equity, and investment banking, most recently serving as Managing Director at Bupa Villages & Aged Care. He has been recognised for leading operational and cultural transformation, driving both growth and improved care standards.

Kinkade replaces Dr Linda Mellors, who will complete her notice period in June after leading the company for over six years. The board expressed its appreciation for Dr Mellors' significant contributions and steady leadership throughout her tenure.

What's next for Regis Healthcare?

Kinkade's appointment signals a focus on operational transformation and strengthening Regis's position in Australia's aged care sector. The Board noted his track record of leading growth in regulated, people-focused businesses, which aligns with Regis Healthcare's strategic objectives.

Shareholders will vote on key elements of Kinkade's remuneration package, including his sign-on equity award, at the upcoming Annual General Meeting. The company expects a smooth transition and ongoing delivery on its growth plans.

Regis Healthcare share price snapshot

Over the past 12 months, Regis Healthcare shares have declined 2%, trailing the S&P/ASX 200 Index (ASX: XJO) which has risen 8% over the same period.

View Original Announcement

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

More on Healthcare Shares

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

Up 64%, 3 reasons this expert predicts Pro Medicus shares will keep on giving

| Bernd Struben

A leading expert forecasts more outperformance from the surging Pro Medicus share price.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Healthcare Shares

Clarity Pharmaceuticals reports new SECuRE trial responses at higher dose

| Laura Stewart

Clarity Pharmaceuticals reports further progress in its SECuRE prostate cancer trial, showing strong PSA responses and new complete responses at…

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Neuren Pharmaceuticals share price rockets: record Q2 DAYBUE sales and royalty upgrade

| James Mickleboro

Second quarter net sales of DAYBUE increased 30%.

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

Why this ASX healthcare stock is at the cusp of a 'Transformational Opportunity' – Expert

| Aaron Bell

This ASX healthcare stock is one to watch.

Read more »

A woman leans forward with her hand behind her ear, as if trying to hear information.
ASX Share Market News

Earnings preview: can Cochlear shares rebound?

| Mark Verhoeven

A decade low share price meets a make-or-break result.

Read more »

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Healthcare Shares

Why I'm watching CSL shares like a hawk in August

| Grace Alvino

A low valuation will look very different depending on what management says about the year ahead.

Read more »

Doctor with stethoscope around neck shrugging.
Earnings Results

CSL reports on 18 August. Can the healthcare giant arrest the slide?

| Mark Verhoeven

A make-or-break result for Australia's fallen biotech giant.

Read more »

An older gentleman leans over his partner's shoulder as she looks at a tablet device while seated at a table.
Healthcare Shares

Regis Healthcare acquires Royal Freemasons' Victorian home care business

| Laura Stewart

Regis Healthcare has announced the acquisition of Royal Freemasons’ home care business, expanding its client base and annualised home care…

Read more »